Atlas Trials

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

Clinical trial NCT07674745 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07674745
Sponsor
University of Alabama at Birmingham
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2026-10-01
Primary completion
2030-09-30
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.